TScan Therapeutics, Inc. (TCRX)

0.2377 +0.03 (+12.87%) USD  |  NASDAQ  |  Oct 15, 16:00
0.2377 0.00 (0.00%) After-Hours: 20:00
More

TScan Therapeutics EPS Diluted (Quarterly) : -0.2336 for June 30, 2026

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -0.2336
March 31, 2026 -0.2206
December 31, 2025 -0.1769
September 30, 2025 -0.275
June 30, 2025 -0.2848
March 31, 2025 -0.2632
December 31, 2024 -0.2965
September 30, 2024 -0.2518
June 30, 2024 -0.2791
March 31, 2024 -0.3177
December 31, 2023 -0.4101
September 30, 2023 -0.2425
Date Value
June 30, 2023 -0.5093
March 31, 2023 -0.9314
December 31, 2022 -0.7728
September 30, 2022 -0.6748
June 30, 2022 -0.6274
March 31, 2022 -0.6739
December 31, 2021 -0.594
September 30, 2021 -0.7969
June 30, 2021 -0.4538
March 31, 2021 -0.2354
June 30, 2020 -0.2386
March 31, 2020 -0.3364

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Agenus, Inc. -0.0146
Amgen, Inc. 4.366
Anika Therapeutics, Inc. 0.2412
BioCryst Pharmaceuticals, Inc. 0.2957
Imunon, Inc. -0.5412

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -30.36M
Revenue (Quarterly) 1.051M
Total Expenses (Quarterly) 31.41M
Enterprise Value 5.011M
Gross Profit Margin (Quarterly) 33.49%
Profit Margin (Quarterly) -2.89K%
Earnings Yield -381.2%
Normalized Earnings Yield -381.28